Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $1.04 billion. The enterprise value is $872.09 million.
| Market Cap | 1.04B |
| Enterprise Value | 872.09M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTA has 98.77 million shares outstanding.
| Shares Outstanding | 98.77M |
| Owned by Insiders (%) | 2.33% |
| Owned by Institutions (%) | 84.02% |
| Float | 43.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 152.35 |
| Forward PS | n/a |
| PB Ratio | 4.42 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 127.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.00, with a Debt / Equity ratio of 0.36.
| Current Ratio | 8.00 |
| Quick Ratio | n/a |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.78 |
Financial Efficiency
Return on equity (ROE) is -56.70% and return on invested capital (ROIC) is -55.08%.
| Return on Equity (ROE) | -56.70% |
| Return on Assets (ROA) | -39.40% |
| Return on Capital (ROIC) | -55.08% |
| Revenue Per Employee | $90,171 |
| Profits Per Employee | -$1.99M |
| Employee Count | 76 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -25.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +119.30% in the last 52 weeks. The beta is 1.39, so CNTA's price volatility has been higher than the market average.
| Beta (1Y) | 1.39 |
| 52-Week Price Change | +119.30% |
| 50-Day Moving Average | 10.82 |
| 200-Day Moving Average | 7.92 |
| Relative Strength Index (RSI) | 46.49 |
| Average Volume (30 Days) | 399,851 |
Short Selling Information
| Short Interest | 1.74M |
| Short Previous Month | 1.54M |
| Short % of Shares Out | 2.35% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.43 |
Income Statement
In the last 12 months, CNTA had revenue of $6.85 million and -$151.09 million in losses. Loss per share was -$1.57.
| Revenue | 6.85M |
| Gross Profit | 6.85M |
| Operating Income | -176.71M |
| Pretax Income | -176.14M |
| Net Income | -151.09M |
| EBITDA | -165.43M |
| EBIT | -166.24M |
| Loss Per Share | -$1.57 |
Balance Sheet
The company has $256.55 million in cash and $84.59 million in debt, giving a net cash position of $171.96 million or $1.74 per share.
| Cash & Cash Equivalents | 256.55M |
| Total Debt | 84.59M |
| Net Cash | 171.96M |
| Net Cash Per Share | $1.74 |
| Equity / Book Value | 236.24M |
| Book Value Per Share | 2.39 |
| Working Capital | 275.71M |
Cash Flow
In the last 12 months, operating cash flow was -$160.34 million and capital expenditures -$169,000, giving a free cash flow of -$160.51 million.
| Operating Cash Flow | -160.34M |
| Capital Expenditures | -169,000 |
| Free Cash Flow | -160.51M |
| FCF Per Share | -$1.67 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,578.59% and -2,204.65%.
| Gross Margin | 100.00% |
| Operating Margin | -2,578.59% |
| Pretax Margin | -2,570.28% |
| Profit Margin | -2,204.65% |
| EBITDA Margin | -2,413.91% |
| EBIT Margin | -2,425.73% |
| FCF Margin | -2,342.20% |
Dividends & Yields
CNTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.97% |
| Shareholder Yield | -2.97% |
| Earnings Yield | -14.47% |
| FCF Yield | -15.37% |
Analyst Forecast
The average price target for CNTA is $10.00, which is -5.39% lower than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | -5.39% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 118.00% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CNTA has an Altman Z-Score of 1.54. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.54 |
| Piotroski F-Score | n/a |